Literature DB >> 31712098

Epidemiology Characteristics and Outcome of Patients With Clinically Diagnosed Acute Myocarditis.

Anan Younis1, Shlomi Matetzky2, Wesam Mulla3, Eyas Masalha2, Yoav Afel2, Fernando Chernomordik2, Alex Fardman2, Orly Goitein2, Sagit Ben-Zekry2, Yael Peled2, Avishay Grupper2, Roy Beigel2.   

Abstract

BACKGROUND: There are controversial data regarding the outcome and management of patients hospitalized with clinically diagnosed acute myocarditis.
METHODS: We retrospectively evaluated data of 322 consecutive patients admitted to the Sheba Medical Center with clinically suspected acute myocarditis from January 2005 to December 2017. Patients were subdivided into 2 groups based on their left ventricular ejection fraction (LVEF) at presentation: 1) patients with an LVEF <50% (n = 60) and 2) patients with an LVEF ≥50% (n = 260). We aimed to evaluate the clinical characteristics, management, and in-hospital outcome as well as short-term and 1-year outcome of patients admitted with acute myocarditis.
RESULTS: The mean age of the study population was 37 ± 14 years, most of them (84%) males. Although chest pain was the main complaint in 89% of the patients at presentation, only 35% had typical pericardial pain. Patients with a LVEF <50% were more likely to demonstrate ST depression or T wave inversion on their electrocardiogram (ECG) at presentation (33% vs 18%, P = 0.007), and have higher levels of admission and peak troponin compared to those with LVEF ≥50%,(12.7 μ/L ± 15 µ/L vs 5.5 μ/L ± 9.2 μ/L, P = 0.001 for admission troponin, 18.8 μ/L ± 19.9 μ/L vs 8.4 μ/L ± 11.6 μ/L, P <0.001, for peak troponin). Univariate analysis showed that patients with an LVEF <50% were more likely to suffer from adverse cardiovascular events, defined as a composite of the following: 1) acute decompensated congestive heart failure; 2) ventricular arrhythmias; and 3) in-hospital mortality, compared to those with an LVEF ≥50% (15 [25%] vs10 [4%], P <0.001). Consistently, multivariable analysis showed that patients with an LVEF <50% had a 4-fold increased risk of adverse cardiovascular events compared to those patients with an LVEF ≥50% (heart rate [HR] = 4.30; 95% confidence interval [CI] 1.59-11.49; P <0.001).
CONCLUSIONS: Patients with clinical acute myocarditis seem to have an overall good prognosis. Although patients with an LVEF <50% are at a higher risk of in-hospital adverse events compared to those with an LVEF ≥50%, this propensity is not reflected during 1-year of follow-up.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myocarditis; In-hospital outcome; Prognosis

Year:  2019        PMID: 31712098     DOI: 10.1016/j.amjmed.2019.10.015

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Acute myocarditis: aetiology, diagnosis and management.

Authors:  Temi Lampejo; Simon M Durkin; Naman Bhatt; Oliver Guttmann
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

Review 2.  Neurological Manifestations of Myocarditis.

Authors:  Gabriela Trifan; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-19       Impact factor: 6.030

3.  Clinical and Cardiovascular Magnetic Resonance Predictors of Early and Long-Term Clinical Outcome in Acute Myocarditis.

Authors:  Yohann Bohbot; Jérôme Garot; Thomas Hovasse; Thierry Unterseeh; Chloé Di Lena; Wahiba Boukefoussa; Chloé Tawa; Cédric Renard; Isabelle Limouzineau; Suzanne Duhamel; Philippe Garot; Christophe Tribouilloy; Francesca Sanguineti
Journal:  Front Cardiovasc Med       Date:  2022-04-29

4.  Myocarditis following COVID-19 vaccination - A case series.

Authors:  Dan Levin; Gil Shimon; Maggie Fadlon-Derai; Liron Gershovitz; Amiram Shovali; Anat Sebbag; Shakib Bader; Noam Fink; Barak Gordon
Journal:  Vaccine       Date:  2021-09-04       Impact factor: 3.641

5.  Fulminant myocarditis in adults: a narrative review.

Authors:  Santiago Montero; Darryl Abrams; Enrico Ammirati; Florent Huang; Dirk W Donker; Guillaume Hekimian; Cosme García-García; Antoni Bayes-Genis; Alain Combes; Matthieu Schmidt
Journal:  J Geriatr Cardiol       Date:  2022-02-28       Impact factor: 3.327

6.  Myocarditis after BNT162b2 and mRNA-1273 COVID-19 vaccination: A report of 7 cases.

Authors:  Sirwan Khalid Ahmed
Journal:  Ann Med Surg (Lond)       Date:  2022-04-21

7.  T-wave inversion as a manifestation of COVID-19 infection: a case series.

Authors:  Jorge Romero; Isabella Alviz; Michael Parides; Juan Carlos Diaz; David Briceno; Mohamed Gabr; Maria Gamero; Kavisha Patel; Eric D Braunstein; Sutopa Purkayastha; Dalvert Polanco; Carolina R Valencia; Domenico Della Rocca; Alejandro Velasco; Ruike Yang; Nicola Tarantino; Xiao-Dong Zhang; Sanghamitra Mohanty; Juan Bello; Andrea Natale; Ulrich P Jorde; Mario Garcia; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2020-10-31       Impact factor: 1.900

8.  Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Authors:  Enrico Ammirati; Maria Frigerio; Leslie T Cooper; Paolo G Camici; Eric D Adler; Cristina Basso; David H Birnie; Michela Brambatti; Matthias G Friedrich; Karin Klingel; Jukka Lehtonen; Javid J Moslehi; Patrizia Pedrotti; Ornella E Rimoldi; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circ Heart Fail       Date:  2020-11-12       Impact factor: 8.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.